Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose

被引:46
作者
Wiström, J [1 ]
Ahlm, C
Lundberg, S
Settergren, B
Tärnvik, A
机构
[1] Univ Umea Hosp, Dept Infect Dis, S-90185 Umea, Sweden
[2] Danderyd Hosp, Dept Infect Dis, S-18288 Danderyd, Sweden
关键词
hepatitis B; vaccination; immunity;
D O I
10.1016/S0264-410X(99)00012-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
We here studied the antibody response to a booster dose four years after the administration of one single dose of recombinant HE vaccine. Before receiving the booster dose, levels of protective antibodies (anti-HBs) were generally low and 24/41 (59%) individuals lacked detectable antibodies (<1 IU/L). Within 14 d of booster vaccination, 36/38 (95%) vaccinees showed levels of antibodies > 100 IU/L. Notably, these levels were at least as high as those of a reference group 12 months after initiation of vaccination according to the standard three-dose vaccination at intervals of 0, 1 and 6 months. In conclusion, one single dose of HE vaccine seemed to confer on young healthy individuals a well preserved B cell memory, disclosed as a rapid and strong antibody response to a second dose four years later. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2162 / 2165
页数:4
相关论文
共 15 条
[1]
Prediction of response to hepatitis B vaccine in health care workers: Whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness? [J].
Alimonos, K ;
Nafziger, AN ;
Murray, J ;
Bertino, JS .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (03) :566-571
[2]
*CDC, 1991, MMWR-MORBID MORTAL W, V40, P11
[3]
Predictors of hepatitis B vaccine acceptance in health care workers [J].
Doebbeling, BN ;
Ferguson, KJ ;
Kohout, FJ .
MEDICAL CARE, 1996, 34 (01) :58-72
[4]
Immunogenicity of two doses of yeast recombinant hepatitis B vaccine in healthy older adults [J].
Gellin, BG ;
Greenberg, RN ;
Hart, RH ;
Bertino, JS ;
Stein, DH ;
Deloria, MA ;
ClementsMann, ML .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) :1494-1497
[5]
DISTINCT SHORT-LIVED AND LONG-LIVED ANTIBODY-PRODUCING CELL-POPULATIONS [J].
HO, F ;
LORTAN, JE ;
MACLNNAN, ICM ;
KHAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (10) :1297-1301
[6]
HOLLINGER FB, 1989, AM J MED S3A, V87, P36
[7]
DURATION OF IMMUNITY AFTER HEPATITIS-B VACCINATION - EFFICACY OF LOW-DOSE BOOSTER VACCINE [J].
HOROWITZ, MM ;
ERSHLER, WB ;
MCKINNEY, WP ;
BATTIOLA, RJ .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :185-189
[8]
4-YEAR EXPERIENCE WITH A RECOMBINANT HEPATITIS-B VACCINE [J].
JILG, W ;
SCHMIDT, M ;
DEINHARDT, F .
INFECTION, 1989, 17 (02) :70-76
[9]
A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults [J].
Marsano, LS ;
West, DJ ;
Chan, I ;
Hesley, TM ;
Cox, J ;
Hackworth, V ;
Greenberg, RN .
VACCINE, 1998, 16 (06) :624-629
[10]
MAINTENANCE OF B-CELL MEMORY BY LONG-LIVED CELLS GENERATED FROM PROLIFERATING PRECURSORS [J].
SCHITTEK, B ;
RAJEWSKY, K .
NATURE, 1990, 346 (6286) :749-751